Literature DB >> 11862624

BSE infection of the small short-lived primate Microcebus murinus.

Noëlle Bons1, Sylvain Lehmann, Noriyuki Nishida, Nadine Mestre-Frances, Dominique Dormont, Patrick Belli, Andre Delacourte, Jacques Grassi, Paul Brown.   

Abstract

Eleven Microcebus murinus (lemur) primates were intracerebrally or orally infected by bovine spongiform encephalopathy (BSE) or macaque-adapted BSE (MBSE) brain homogenates. In many BSE and MBSE infected lemurs, but not in animals inoculated with normal bovine brain, persistent behavioral changes occurred as early as 3 months, and neurological signs as early as 13 months after infection. Immunohistochemical examination of animals sacrificed during the incubation period revealed an abnormal accumulation of 'prion' protein (PrP) in the intestinal wall, intestinal nervous plexus, mesenteric lymph nodes and spleen, and in the clinical stage, also in the brain. In MBSE-inoculated animals, proteinase K resistance of the PrP (PrPres) was confirmed by Western blot in the spleen and the brain. Obvious signs of neurodegeneration were observed in all infected animals characterized by hyperaggregated and paired-helical filaments-immunoreactive Tau proteins, beta 42-amyloid plaques and astrogliosis. Additionally, PrPres was present in the ganglion cells of the retina in diseased animals after either intracerebrally or oral infection by the BSE or MBSE agent. These results show that the microcebe is susceptible to the BSE infectious agent via intracerebral and oral routes with comparatively short incubation periods compared to simians, and could be a useful animal model to study the pathophysiology of disease transmission in primates.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11862624     DOI: 10.1016/s1631-0691(02)01390-2

Source DB:  PubMed          Journal:  C R Biol        ISSN: 1631-0691            Impact factor:   1.583


  6 in total

1.  Squirrel monkeys (Saimiri sciureus) infected with the agent of bovine spongiform encephalopathy develop tau pathology.

Authors:  P Piccardo; J Cervenak; O Yakovleva; L Gregori; K Pomeroy; A Cook; F S Muhammad; T Seuberlich; L Cervenakova; D M Asher
Journal:  J Comp Pathol       Date:  2011-10-20       Impact factor: 1.311

Review 2.  Non-human primates in prion diseases.

Authors:  Emmanuel E Comoy; Jacqueline Mikol; Jean-Philippe Deslys
Journal:  Cell Tissue Res       Date:  2022-06-04       Impact factor: 5.249

3.  Oral transmission of L-type bovine spongiform encephalopathy in primate model.

Authors:  Nadine Mestre-Francés; Simon Nicot; Sylvie Rouland; Anne-Gaëlle Biacabe; Isabelle Quadrio; Armand Perret-Liaudet; Thierry Baron; Jean-Michel Verdier
Journal:  Emerg Infect Dis       Date:  2012-01       Impact factor: 6.883

Review 4.  Prion Strains and Transmission Barrier Phenomena.

Authors:  Angélique Igel-Egalon; Vincent Béringue; Human Rezaei; Pierre Sibille
Journal:  Pathogens       Date:  2018-01-01

Review 5.  Bovine Spongiform Encephalopathy 
- A Review from the Perspective of Food Safety.

Authors:  Susumu Kumagai; Takateru Daikai; Takashi Onodera
Journal:  Food Saf (Tokyo)       Date:  2019-06-13

6.  PrP aggregation can be seeded by pre-formed recombinant PrP amyloid fibrils without the replication of infectious prions.

Authors:  Rona M Barron; Declan King; Martin Jeffrey; Gillian McGovern; Sonya Agarwal; Andrew C Gill; Pedro Piccardo
Journal:  Acta Neuropathol       Date:  2016-07-04       Impact factor: 17.088

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.